MediWound Ltd.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-23.9M | $-30.2M | $-6.7M | $-19.6M | $-13.6M | $-9.2M | $5.0M | $-1.1M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-16.1M | $-13.6M | $-10.5M | $-11.9M | $-8.9M | $-6.9M | $8.3M | $-12.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $5.5M | $6.3M | $6.5M | $555.0K | $489.0K | $923.0K | $792.0K | $522.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-18.0M | $-8.4M | $-34.3M | $-481.0K | $3.5M | $17.4M | $-6.9M | $-17.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $29.6M | $19.4M | $22.9M | $35.8M | $-1.1M | — | — | $46.0K |
| Net Change in Cash | $-4.4M | $-2.7M | $-22.0M | $22.8M | $-6.3M | $10.3M | $3.4M | $-29.4M |
| Free Cash Flow | $-21.6M | $-19.9M | $-16.9M | $-12.4M | $-9.4M | $-7.8M | $7.5M | $-12.7M |